Menopause
HRT (hormone replacement therapy) may not increase breast cancer risk in women with BRCA mutations, new research suggests. Women who inherit harmful mutations in the BRCA1 or BRCA2 genes, which help repair DNA, face elevated risks of ovarian and breast cancer. They are often advised to have their ovaries and fallopian tubes surgically removed (bilateral [...]
Most Americans are unaware that midwives provide women's healthcare beyond pregnancy and birth, a new survey has found. The survey of 1,006 Americans found that 93 per cent think midwives only deliver babies and were surprised to learn they can be a trusted partner in all aspects of women's health. The research was conducted by [...]
An overlooked fat-derived hormone may drive higher breast cancer death risk in postmenopausal women with obesity, an analysis suggests. The review identifies oestrone, a form of oestrogen produced in fat tissue, as a major driver of oestrogen receptor positive (ER+) breast cancer, the most common and deadly form of the disease in postmenopausal women. ER+ [...]
Joi + Blokes acquires HerMD, creating a virtual women’s health platform serving all 50 US states after HerMD’s shift to online-only care in spring 2025. HerMD relaunched as a virtual-only platform in spring 2025 after closing its physical sites in March 2025. Financial terms were not disclosed. The company had previously raised about US$30m, including [...]
Femtech World explores the latest business developments in the world of women's health. First wearable detects and decodes the symptoms of perimenopause AI-driven women's health company, IdentifyHer, has launched Peri, the world's first wearable designed to detect and decode symptoms of perimenopause. "75 per cent of perimenopausal women experience life-disrupting symptoms, yet perimenopause is treated [...]
A new commercially available genetic test for perimenopausal women has been launched by femtech firm Willbe. The FemGene test is aimed at decoding "how women uniquely experience perimenopause and respond to bioidentical hormone therapy (BHRT)". Perimenopause, affecting over 1 billion women globally, remains one of the most underserved areas of healthcare, WIllbe says. Standard approaches , [...]
Medical experts say the FDA bypassed standard procedures to remove black-box warnings from hormone therapy without adequate scientific evidence. The US Food and Drug Administration commissioner Marty Makary announced the removal of broad black-box warnings from oestrogen-related menopause medications last week, claiming the treatments could prevent heart disease, osteoporosis, Alzheimer's disease and death. Black-box warnings [...]
By Maxime Kryvian, co-founder and CEO of MyCelsius Menopause remains one of the biggest taboos in women’s health. Often treated as a private matter to be discussed quietly, when it is a significant life stage that deeply affects the physical, mental, and social well-being of millions of women. Yet menopause symptoms are still [...]
Bristol-based femtech firm Emm has raised US$9m in seed funding for its smart menstrual cup that tracks and analyses the menstrual cycle. Established in 2020 by Jenny Button, Emm is developing the world's first smart menstrual cup. The device combines medical-grade silicone with integrated biosensors to measure menstrual flow, cup usage and cycle patterns. Data [...]
Online supermarket Ocado has launched a menopause aisle with more than 300 products, billed as the UK's largest, to help menopausal women find support and clearer symptom guidance. The aisle, developed with menopause organisation GenM, brings together MTick-certified products across supplements, skincare, sexual health and personal care. Shoppers can access guidance that matches products to [...]
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
















